• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于主动脉感染的股静脉重建术。

Femoral Vein Reconstruction for Aortic Infections.

作者信息

Pallister Zachary S, Chung Jayer

机构信息

Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

出版信息

Vasc Specialist Int. 2021 Mar 31;37(1):4-13. doi: 10.5758/vsi.210002.

DOI:10.5758/vsi.210002
PMID:33795548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021492/
Abstract

While rare, abdominal aortic infections remain one of the most technically and emotionally challenging cases that a vascular surgeon may face. Secondary infections of either endovascular, or open aortic reconstructions range from 0.2% to 8%. Primary aortic infections are much more rare. Diagnosis can be elusive, depending upon the virulence of the causative microbes, and extent of the infection. Patients are often brittle, with immunocompromise and malnutrition prevalent in this patient population. The gold standard diagnostic test remains a computed tomographic angiogram. The mainstay of management requires vascular control, and wide debridement of all infected materials and revascularization. Multiple methods exist to reconstruct the vascular supply. The neo-aortoiliac system (NAIS) is attractive as it utilizes the patient's own femoral veins to reconstruct the vascular supply after the infection has been extirpated. The procedure is demanding upon the patient and surgeons alike. Also, the rarity of aortic infections limit experiences the literature to centers of excellence. However, the NAIS resists infection well, leaving the patient without any remaining foreign bodies. No further costs for conduit are incurred. Moreover, multiple experiences show excellent durability. While comparative effectiveness literature remains sparse, we believe the NAIS to be the optimal method of revascularization for select patients. In this article, we will review the use of NAIS for primary and secondary aortic infections. In particular, we will emphasize procedural details to help enable the reader to apply this procedure most effectively to their own patients.

摘要

腹主动脉感染虽然罕见,但仍然是血管外科医生可能面临的技术和情感上最具挑战性的病例之一。血管腔内修复术或开放性主动脉重建术后的继发感染率为0.2%至8%。原发性主动脉感染则更为罕见。诊断可能很困难,这取决于致病微生物的毒力和感染程度。这类患者通常身体状况较差,免疫功能低下和营养不良很常见。金标准诊断测试仍然是计算机断层血管造影。治疗的主要方法需要控制血管、广泛清除所有感染物质并进行血管重建。存在多种重建血管供应的方法。新主动脉髂动脉系统(NAIS)很有吸引力,因为它在感染被清除后利用患者自身的股静脉来重建血管供应。该手术对患者和外科医生都要求很高。此外,主动脉感染的罕见性使得文献报道多限于一些卓越中心的经验。然而,NAIS抗感染能力良好,患者体内不会残留任何异物。无需额外的管道费用。而且,多项经验表明其耐久性极佳。虽然比较有效性的文献仍然很少,但我们认为NAIS是某些特定患者血管重建的最佳方法。在本文中,我们将回顾NAIS在原发性和继发性主动脉感染中的应用。特别是,我们将强调手术细节,以帮助读者最有效地将该手术应用于自己的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/535a63260db6/vsi-37-1-4-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/eed1d6f6cc5a/vsi-37-1-4-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/89e21bde6688/vsi-37-1-4-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/07b644233f61/vsi-37-1-4-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/10c0586a6967/vsi-37-1-4-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/877139babc4e/vsi-37-1-4-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/9a7bbb215cc4/vsi-37-1-4-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/535a63260db6/vsi-37-1-4-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/eed1d6f6cc5a/vsi-37-1-4-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/89e21bde6688/vsi-37-1-4-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/07b644233f61/vsi-37-1-4-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/10c0586a6967/vsi-37-1-4-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/877139babc4e/vsi-37-1-4-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/9a7bbb215cc4/vsi-37-1-4-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c3/8021492/535a63260db6/vsi-37-1-4-f7.jpg

相似文献

1
Femoral Vein Reconstruction for Aortic Infections.用于主动脉感染的股静脉重建术。
Vasc Specialist Int. 2021 Mar 31;37(1):4-13. doi: 10.5758/vsi.210002.
2
Deep Femoral Vein Reconstruction of the Abdominal Aorta and Adaptation of the Neo-Aortoiliac System Bypass Technique in an Endovascular Era.腹主动脉股深静脉重建及血管腔内时代新主动脉-髂动脉系统旁路技术的应用
Vasc Endovascular Surg. 2019 Jan;53(1):28-34. doi: 10.1177/1538574418801100. Epub 2018 Sep 19.
3
Variant Neo-Aortoiliac System Operation Using a Composite Conduit of Silver-Coated Dacron Graft and Autologous Femoral Veins: A Report of Two Cases.使用银涂层涤纶人工血管与自体股静脉复合管道的改良型新主动脉-髂动脉系统手术:两例报告
Vasc Specialist Int. 2021 Jul 9;37:20. doi: 10.5758/vsi.210022.
4
Unilateral inline replacement of infected aortofemoral graft limb with femoral vein.采用股静脉对感染的主动脉股动脉移植肢体进行单侧原位置换。
J Vasc Surg. 2017 Apr;65(4):1121-1129. doi: 10.1016/j.jvs.2016.09.051. Epub 2017 Feb 9.
5
Staging the neoaortoiliac system: feasibility and short-term outcomes.新主动脉-髂血管系统分期:可行性与短期结果
J Vasc Surg. 2008 Nov;48(5):1125-30; discussion 1130-1. doi: 10.1016/j.jvs.2008.06.067. Epub 2008 Sep 19.
6
Contemporary Experience of the Neo-Aortoiliac System (NAIS) Procedure: A Case Series with Review of the Literature.当代新型腹主动脉-髂动脉系统(NAIS)手术的经验:病例系列及文献复习。
Ann Vasc Surg. 2024 Dec;109:358-369. doi: 10.1016/j.avsg.2024.05.033. Epub 2024 Jul 15.
7
Creation of a neo-aortoiliac system from lower extremity deep and superficial veins.利用下肢深浅静脉构建新的主-髂动脉系统。
Ann Surg. 1993 Sep;218(3):239-48; discussion 248-9. doi: 10.1097/00000658-199309000-00003.
8
Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts.采用股腘静脉移植物原位置换治疗主动脉移植物感染的长期结果。
J Vasc Surg. 2009 Jul;50(1):30-9. doi: 10.1016/j.jvs.2009.01.008.
9
Neoaortoiliac System Procedure to Treat Infected Aortic Grafts.治疗感染性主动脉移植物的新主动脉髂动脉系统手术
Ann Vasc Surg. 2017 Oct;44:419.e19-419.e25. doi: 10.1016/j.avsg.2017.04.041. Epub 2017 May 8.
10
Neoaortoiliac System (NAIS) procedure for the treatment of the infected aortic graft.腹主动脉瘤覆膜支架腔内隔绝术(NAIS)治疗感染性主动脉移植物
Semin Vasc Surg. 2011 Dec;24(4):220-6. doi: 10.1053/j.semvascsurg.2011.10.012.

引用本文的文献

1
Successful, staged management of an iliac artery to ileal urinary conduit fistula.髂动脉至回肠代膀胱瘘的成功分期治疗
J Vasc Surg Cases Innov Tech. 2023 Sep 28;9(4):101331. doi: 10.1016/j.jvscit.2023.101331. eCollection 2023 Dec.
2
Successful surgery for secondary aortoduodenal fistula based on F-fluorodeoxyglucose positron emission tomography/computed tomography findings.基于氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描结果的继发性主动脉十二指肠瘘成功手术治疗。
J Vasc Surg Cases Innov Tech. 2023 Mar 21;9(2):101162. doi: 10.1016/j.jvscit.2023.101162. eCollection 2023 Jun.
3
Outcomes of Candida and Non-Candida Aortic Graft Infection.

本文引用的文献

1
In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas.原位旁路和解剖外旁路手术在治疗继发性主动脉肠瘘患者时的生存结果相似。
J Vasc Surg. 2021 Jan;73(1):210-221.e1. doi: 10.1016/j.jvs.2020.04.515. Epub 2020 May 21.
2
Deep Femoral Vein Reconstruction of the Abdominal Aorta and Adaptation of the Neo-Aortoiliac System Bypass Technique in an Endovascular Era.腹主动脉股深静脉重建及血管腔内时代新主动脉-髂动脉系统旁路技术的应用
Vasc Endovascular Surg. 2019 Jan;53(1):28-34. doi: 10.1177/1538574418801100. Epub 2018 Sep 19.
3
Twenty-Year Experience with Aorto-Enteric Fistula Repair: Gastrointestinal Complications Predict Mortality.
念珠菌和非念珠菌性主动脉移植物感染的结果。
Vasc Endovascular Surg. 2023 Feb;57(2):97-105. doi: 10.1177/15385744221129236. Epub 2022 Sep 23.
4
Leriche Syndrome with Digital Gangrene: Is Aortic Bypass Grafting Safe in Intravenous Drug Abusers? A Case Report and Literature Review.伴有指端坏疽的勒里什综合征:主动脉旁路移植术在静脉药物滥用者中是否安全?一例病例报告及文献综述
Vasc Specialist Int. 2022 Mar 31;38:6. doi: 10.5758/vsi.210072.
5
Infected Aortic Aneurysm with Infective Spondylitis in a Patient with Pre-Aortic Confluence of the Iliac Veins: An Unusual Triple Combination.一名髂静脉在主动脉前汇合的患者出现感染性主动脉瘤合并感染性脊柱炎:一种罕见的三联组合。
Vasc Specialist Int. 2021 Dec 29;37:41. doi: 10.5758/vsi.210066.
6
Variant Neo-Aortoiliac System Operation Using a Composite Conduit of Silver-Coated Dacron Graft and Autologous Femoral Veins: A Report of Two Cases.使用银涂层涤纶人工血管与自体股静脉复合管道的改良型新主动脉-髂动脉系统手术:两例报告
Vasc Specialist Int. 2021 Jul 9;37:20. doi: 10.5758/vsi.210022.
主动脉肠瘘修复的 20 年经验:胃肠道并发症预测死亡率。
J Am Coll Surg. 2017 Jul;225(1):9-18. doi: 10.1016/j.jamcollsurg.2017.01.050. Epub 2017 Feb 2.
4
Editor's Choice - Management of Secondary Aorto-enteric and Other Abdominal Arterio-enteric Fistulas: A Review and Pooled Data Analysis.编辑推荐——继发性主动脉-肠瘘及其他腹部动脉-肠瘘的管理:综述与汇总数据分析
Eur J Vasc Endovasc Surg. 2016 Dec;52(6):770-786. doi: 10.1016/j.ejvs.2016.09.014. Epub 2016 Nov 9.
5
Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC).主动脉移植物感染的诊断:主动脉移植物感染协作组(MAGIC)的病例定义
Eur J Vasc Endovasc Surg. 2016 Dec;52(6):758-763. doi: 10.1016/j.ejvs.2016.09.007. Epub 2016 Oct 19.
6
Treatment and outcomes of aortic endograft infection.主动脉腔内移植物感染的治疗与预后
J Vasc Surg. 2016 Feb;63(2):332-40. doi: 10.1016/j.jvs.2015.08.113.
7
A multicenter experience with the surgical treatment of infected abdominal aortic endografts.感染性腹主动脉腔内移植物手术治疗的多中心经验
J Vasc Surg. 2015 Oct;62(4):877-83. doi: 10.1016/j.jvs.2015.04.440. Epub 2015 Jul 14.
8
Modest utility of quantitative measures in (18)F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection.定量测量在(18)F-氟脱氧葡萄糖正电子发射断层扫描用于诊断主动脉人工血管感染中的有限效用。
J Vasc Surg. 2015 Apr;61(4):965-71. doi: 10.1016/j.jvs.2014.11.005. Epub 2014 Dec 10.
9
Native Aortic and Prosthetic Vascular Stent Infection on 99mTc-Labeled White Blood Cell Scintigraphy.99mTc 标记白细胞闪烁扫描术检测天然主动脉及人工血管支架感染
J Nucl Med Technol. 2014 Jun;42(2):120-1. doi: 10.2967/jnmt.113.127704. Epub 2014 Feb 20.
10
Neoaortoiliac System (NAIS) procedure for the treatment of the infected aortic graft.腹主动脉瘤覆膜支架腔内隔绝术(NAIS)治疗感染性主动脉移植物
Semin Vasc Surg. 2011 Dec;24(4):220-6. doi: 10.1053/j.semvascsurg.2011.10.012.